Abstract
Hemodynamic assessment of patients with pulmonary embolism (PE) remains a fundamental component of early risk stratification that in turn, influences subsequent monitoring and therapeutic strategies. The current body of literature and international evidence-based clinical practice guidelines focus mainly on the use of systolic blood pressure (SBP). The accuracy of this single hemodynamic parameter, however, and its optimal values for the identification of hemodynamic instability have been recently questioned by clinicians. For example, abnormal SBP or shock index may be a late indicator of adverse outcomes, signaling a patient in whom the cascade of hemodynamic compromise is already well underway. The aim of the present article is to review the current evidence supporting the use of SBP and analyze the potential integration of other parameters to assess the hemodynamic stability, impending clinical deterioration, and guide the reperfusion treatment in patients with PE, as well as to suggest potential strategies to further investigate this issue.
Graphical Abstract
Similar content being viewed by others
References
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL, ESC Scientific Document Group (2020) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, thrombosis and Vascular Biology (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830
Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, Huisman MV, Kearon C, King CS, Knighton AJ, Lake E, Murin S, Vintch JRE, Wells PS, Moores LK (2021) Executive Summary: antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest 160:2247–2259
Zuin M, Bikdeli B, Armero A, Porio N, Rigatelli G, Bilato C, Piazza G (2023) Trends in Pulmonary Embolism deaths among young adults aged 25 to 44 years in the United States, 1999 to 2019. Am J Cardiol 202:169–175
Zuin M, Bikdeli B, Davies J, Krishnathasan D, Rigatelli G, Roncon L, Bilato C, Piazza G (2023) Contemporary trends in mortality related to high-risk pulmonary embolism in US from 1999 to 2019. Thromb Res 228:72–80
Jiménez D, Bikdeli B, Barrios D, Quezada A, Del Toro J, Vidal G, Mahé I, Quere I, Loring M, Yusen RD, Monreal M, RIETE investigators (2018) Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int J Cardiol 269:327–333
Secemsky E, Chang Y, Jain CC, Beckman JA, Giri J, Jaff MR, Rosenfield K, Rosovsky R, Kabrhel C, Weinberg I (2018) Contemporary Management and outcomes of patients with massive and submassive pulmonary embolism. Am J Med 131:1506–1514e0
Zhao S, Friedman O (2020) Management of right ventricular failure in pulmonary embolism. Crit Clin Care 35:505–515
Kucher N, Rossi E, De Rosa M, Goldhaber SZ (2005) Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm hg or higher. Arch Intern Med 165:1777–1781
Bangalore S, Horowitz JM, Beam D, Jaber WA, Khandhar S, Toma C, Weinberg MD, Mina B (2023) Prevalence and predictors of cardiogenic shock in Intermediate-Risk Pulmonary Embolism: insights from the FLASH Registry. JACC Cardiovasc Interv 16:958–972
Zuin M, Rigatelli G, Picariello C, Carraro M, Zonzin P, Roncon L (2017) Prognostic role of a new risk index for the prediction of 30-day cardiovascular mortality in patients with acute pulmonary embolism: the Age-Mean arterial pressure index (AMAPI). Heart Vessels 32:1478–1487
Otero R, Trujillo-Santos J, Cayuela A et al (2007) Haemodynamically unstable pulmonary embolism in the RIETE registry. Systolic blood pressure or shock index? Eur Respir J 30:1111–1116
Zuin M, Rigatelli G, Bongarzoni A, Enea I, Bilato C, Zonzin P, Casazza F, Roncon L (2023) Mean arterial pressure predicts 48 h clinical deterioration in intermediate-high risk patients with acute pulmonary embolism. Eur Heart J Acute Cardiovasc Care 12:80–86
Chen J, Lin J, Wu D, Guo X, Li X, Shi S (2020) Optimal Mean arterial pressure within 24 hours of admission for patients with Intermediate-Risk and High-Risk Pulmonary Embolism. Clin Appl Thromb Hemost 26:1076029620933944
Zuin M, Rigatelli G, Daggubati R, Nguyen T, Roncon L (2020) Impella RP in hemodynamically unstable patients with acute pulmonary embolism. J Artif Organs 23:105–112
Desai PV, Krepostman N, Collins M, De Sirkar S, Hinkleman A, Walsh K, Fareed J, Darki A (2021) Neurological complications of Pulmonary Embolism: a literature review. Curr Neurol Neurosci Rep 21:59
Murgier M, Bertoletti L, Darmon M, Zeni F, Valle R, Del Toro J, Llamas P, Mazzolai L, Villalobos A, Monreal M, RIETE Investigators (2019) Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry. Int J Cardiol 291:121–126
Aslan S, Meral M, Akku M, Acemoglu H, Ucar EY, Gorguner M, Mirici A (2007) Liver dysfunction in patients with acute pulmonary embolism. Hepatic Res 37:205–213
Marbach JA, Di Santo P, Kapur NK, Thayer KL, Simard T, Jung RG, Parlow S, Abdel-Razek O, Fernando SM, Labinaz M, Froeschl M, Mathew R, Hibbert B (2022) Lactate Clearance as a surrogate for mortality in cardiogenic shock: insights from the DOREMI Trial. J Am Heart Assoc 11:e023322
Elder M, Blank N, Kaki A, Alraies MC, Grines CL, Kajy M, Hasan R, Mohamad T, Schreiber T (2018) Mechanical circulatory support for acute right ventricular failure in the setting of pulmonary embolism. J Interv Cardiol 31:518–524
Revelly JP, Tappy L, Martinez A, Bollmann M, Cayeux MC, Berger MM, Chiolero RL (2005) Lactate and glucose metabolism in severe sepsis and cardiogenic shock. Crit Care Med 33:2235–2240
Otero R, Trujillo-Santos J, Cayuela A, Rodríguez C, Barron M, Martín JJ, Monreal M, Registro Informatizado de la Enfermedad Tromboembólica (RIETE) Investigators (2007) Haemodynamically unstable pulmonary embolism in the RIETE Registry: systolic blood pressure or shock index? Eur Respir J 30:1111–1116
Zuin M, Rigatelli G, Bilato C, Bongarzoni A, Casazza F, Zonzin P, Roncon L (2022) Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry. Thromb Res 217:15–21
Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A (2014) Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40:1795–1815
Picone DS, Schultz MG, Otahal P, Aakhus S, Al-Jumaily AM, Black AJ et al (2017) Accuracy of cuff-measured blood pressure: systematic reviews and meta-analyses. J Am Coll Cardiol 70:572–586
Geibel A, Zehender M, Kasper W, Olschewski M, Klima C, Konstantinides SV (2005) Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur Respir J 25:843–848
Nielsen TT, Lund O, Rønne K, Schifter S (1989) Changing electrocardiographic findings in pulmonary embolism in relation to vascular obstruction. Cardiology 76:274–284
Zuin M, Rigatelli G, Zonzin P, Casazza F, Roncon L (2018) Short- and long-term prognostic role of diastolic blood pressure in intermediate-high risk patients with acute pulmonary embolism. Eur J Intern Med 55:e23–e24
Sheng FQ, Xu R, Xia JD, He MR (2017) ECG patterns indicate severity of Acute Pulmonary Embolism: insights from serial ECG changes in a patient treated with Thrombolysis. J Emerg Med 52:e251–e253
Magder S (2018) The meaning of blood pressure. Crit Care 22:257
Keller K, Beule J, Coldewey M, Dippold W, Balzer JO (2015) Impact of advanced age on the severity of normotensive pulmonary embolism. Heart Vessels 30:647–656
Ramos A, Murillas J, Mascías C, Carretero B, Portero JL (2000) Influence of age on clinical presentation of acute pulmonary embolism. Arch Gerontol Geriatr 30:189–198
Jaureguízar A, Jiménez D, Bikdeli B, Ruiz-Artacho P, Muriel A, Tapson V, López-Reyes R, Valero B, Kenet G, Monreal M, Registro Informatizado De La Enfermedad TromboEmbólica investigators (2022) Heart rate and mortality in patients with Acute Symptomatic Pulmonary Embolism. Chest 161:524–534
Aujesky D, Roy PM, Le Manach CP et al (2006) Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 27:476–481
Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F, Otero R, Monreal M, Muriel A, Yusen RD, RIETE Investigators (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389
Bova C, Vanni S, Prandoni P, Morello F, Dentali F, Bernardi E, Mumoli N, Bucherini E, Barbar S, Picariello C, Enea I, Pesavento R, Bottino F, Jiménez D, Bova Score Validation Study Investigators (2018) A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. Thromb Res 165:107–111
Hobohm L, Becattini C, Konstantinides SV, Casazza F, Lankeit M (2020) Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism. Clin Res Cardiol 109:1008–1017
Hobohm L, Becattini C, Ebner M, Lerchbaumer MH, Casazza F, Hasenfuß G, Konstantinides SV, Lankeit M (2020) Definition of tachycardia for risk stratification of pulmonary embolism. Eur J Intern Med 82:76–82
Goldhaber SZ, Elliott CG (2003) Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation 108:2726–2729
Zuin M, Rigatelli G (2017) Complete heart block as presenting symptom of massive pulmonary embolism in an elderly patient. J Geriatr Cardiol 14:593–594
Klok FA, Piazza G, Sharp ASP, Ní Ainle F, Jaff MR, Chauhan N, Patel B, Barco S, Goldhaber SZ, Kucher N, Lang IM, Schmidtmann I, Sterling KM, Becker D, Martin N, Rosenfield K, Konstantinides SV (2022) Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. Am Heart J 251:43–53
Jentzer JC, Burstein B, Van Diepen S, Murphy J, Holmes DR Jr, Bell MR, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA (2021) Defining shock and preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit patients. Circ Heart Fail 14:e007678
Yamashita Y, Morimoto T, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Sakamoto J, Togi K, Mabuchi H, Takabayashi K, Kato T, Ono K, Kimura T, COMMAND VTE Registry Investigators (2023) Impact of heart rate at diagnosis on clinical outcomes in patients with Acute Pulmonary Embolism. Am J Cardiol 187:38–47
Casazza F, Becattini C, Bongarzoni A, Cuccia C, Roncon L, Favretto G, Zonzin P, Pignataro L, Agnelli G (2012) Clinical features and short term outcomes of patients with acute pulmonary embolism the Italian Pulmonary Embolism Registry (IPER). Thromb Res 130:847–852
Ebner M, Sentler C, Harjola VP, Bueno H, Lerchbaumer MH, Hasenfuß G, Eckardt KU, Konstantinides SV, Lankeit M (2021) Outcome of patients with different clinical presentations of high-risk pulmonary embolism. Eur Heart J Acute Cardiovasc Care 10:787–796
Del Castillo Gordillo C, Avila Cisternas C, Yanez Vidal F, Appiani Florit F, Ibanez Mora A, Van Grieken Garcia J, Mora Valdes R, Luque Gonzales M, Begazo Gonzales A (2010) The relationship between shock index and measures of cardiac output in cardiogenic shock. Eur Heart J Acute Cardiovasc Care 2021. https://doi.org:10:zuab020.172. [Epub Ahead of print]
Houghton D, Jones TW, Cassidy S, Siervo M, MacGowan GA, Trenell MI, Jakovljevic DG (2016) The effect of age on the relationship between cardiac and vascular function. Mech Ageing Dev 153:1–6
Sam A, Sánchez D, Gómez V, Wagner C, Kopecna D, Zamarro C, Moores L, Aujesky D, Yusen R, Jiménez Castro D (2011) The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism. Eur Respir J 37:762–766
Meaney E, Alva F, Moguel R, Meaney A, Alva J, Webe R (2000) Formula and nomogram for the sphygmomanometric calculation of the mean arterial pressure. Heart 84:64
Mathew R, Fernando S, Hu K et al (2022) Optimal perfusion targets in cardiogenic shock. JACC Adv. https://doi.org/10.1016/j.jacadv.2022.100034
Parlow S, Di Santo P, Mathew R, Jung RG, Simard T, Gillmore T, Mao B, Abdel-Razek O, Ramirez FD, Marbach JA, Dick A, Glover C, Russo JJ, Froeschl M, Labinaz M, Fernando SM, Hibbert B, CAPITAL DOREMI investigators (2021) The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial. Eur Heart J Acute Cardiovasc Care 10:712–720
Burstein B, Tabi M, Barsness GW, Bell MR, Kashani K, Jentzer JC (2020) Association between mean arterial pressure during the first 24 hours and hospital mortality in patients with cardiogenic shock. Crit Care 24:513
Chen J, Lin J, Wu D, Guo X, Li X, Shi S (2020) Optimal Mean arterial pressure within 24 hours of admission for patients with Intermediate-Risk and High-Risk Pulmonary Embolism. Clin Appl Thromb Hemost 26:1076029620933944. https://doi.org/10.1177/1076029620933944
Russell JA (2020) Personalized blood pressure targets in shock: what if your normal blood pressure is low? Am J Respir Crit Care Med 202:10–12
Becattini C, Agnelli G, Maggioni AP, Dentali F, Fabbri A, Enea I, Pomero F, Ruggieri MP, Di Lenarda A, Gulizia M (2022) Contemporary clinical management of acute pulmonary embolism: the COPE study. Intern Emerg Med 17:715–723
Piazza G (2020) Advanced Management of Intermediate- and high-risk Pulmonary Embolism: JACC Focus Seminar. J Am Coll Cardiol 76:2117–2127
Hoeper MM, Granton J (2011) Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. AJRCCM 184:1114–1124
Bavaria R, Stals MAM, Mulder FI, Bistervels IM, Coppens M, Faber LM et al (2023) Use of the National Early warning score for predicting deterioration of patients with acute pulmonary embolism: a post-hoc analysis of the YEARS study. Emerg Med J 40:61–66
Kitsios GD, Dahabreh IJ, Callahan S, Paulus JK, Campagna AC, Dargin JM (2015) Can we trust Observational studies using propensity scores in the critical care literature? A systematic comparison with randomized clinical trials. Crit Care Med 43:1870–1879
Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, Wilton SB, Williamson T, Gill S, Drogos LL, Smith EE, Vohra S, Hill MD, Thabane L (2016) Symposium on Registry-Based Randomized Controlled Trials in Calgary (2016) Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research? J Clin Epidemio l80:16–24
Doherty DA, Tong SYC, Reilly J, Shrapnel J, McDonald S, Ahern S, Harris I, Tam CS, Brennan AL, Hodgson C, Wilcox L, Balagurunathan A, Butcher BE, Reid CM (2023) Registry randomised trials: a methodological perspective. BMJ Open 13:e068057
Acknowledgements
Not applicable.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
M.Z. and G.P.: Conceptualization, Methodology, Data curation, Validation.: S.H., E.M.H. Writing—original draft. M.Z. Critical revision; G.P., S. H., E.M.H.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Conflict of interest
GP received research grants from BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Esperion and 1R01HL164717-01. GP reports an advisory Role for BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron. EMH reports research grants from T32-HL0007633 (Brigham and Women’s Hospital, Division of Pulmonary and Critical Care Medicine T32 grant) but has no conflicts of interest. MZ, SH report no potential conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zuin, M., Henkin, S., Harder, E.M. et al. Optimal hemodynamic parameters for risk stratification in acute pulmonary embolism patients. J Thromb Thrombolysis (2024). https://doi.org/10.1007/s11239-024-02998-9
Accepted:
Published:
DOI: https://doi.org/10.1007/s11239-024-02998-9